Clinical Trial Update: High Dose IV Iron Plus ESA in Chemotherapy-induced Anemia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update exploring high-dose intravenous iron combined with erythropoiesis-stimulating agent for chemotherapy-induced anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Snippet

Sponsor: Hallym University Medical Center | Conditions: Anemia | Phase 3 | Status: UNKNOWN